<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FT943-1740</title>
	</head>
	<body>
		<main>
			<p>940922 FT  22 SEP 94 / International Company News: Bristol-Myers completes acquisition of UPSA Bristol-Myers Squibb, the US pharmaceuticals and healthcare group, has announced the completion of its acquisition of UPSA, the French privately-owned pharmaceuticals company. The US group also announced the appointment of Dr Jacques Dardaud as chairman of UPSA. Dr Dardaud, previously chairman of Bristol-Myers France, succeeds Dr Nicolas Bru with immediate effect and will have responsibility for UPSA's worldwide operations. Dr Bru will become president of UPSA's advisory board. UPSA is a research-based company with annual sales of about Dollars 350m. It is one of the leading manufacturers and marketers of analgesics in France and Belgium and has subsidiaries in Belgium, Spain, Italy and Portugal. It also develops and markets cardiovascular and gastrointestinal medicines. Mr Charles Heimbold, chairman of Bristol-Myers Squibb, said the deal would enhance its participation in Europe's growing self-medication market.</p>
		</main>
</body></html>
            